Navigation Links
Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
Date:2/19/2013

on, as a result of the inclusion of legacy Actavis results.

For the full year 2012, Actavis Pharma net revenue increased 32 percent to $4.45 billion, including product sales of $4.39 billion and other revenue of $61.0 million, primarily due to higher international revenues as a result of the acquisitions of Ascent and the Actavis Group in January 2012 and November 2012, respectively, as well as full year sales of the authorized generic versions of Concerta® and Lipitor® in the U.S., launched in May 2011 and November 2011, respectively. 

Actavis Pharma's adjusted gross margin increased from 46.2 percent in 2011 to 46.6 percent in 2012.Actavis Specialty Brands Segment InformationThree Months EndedTwelve Months EndedDecember 31,December 31, (Unaudited; $ in millions)2012201120122011Product sales

$
2.6$
.1$
411.6$
364.9Other revenue

19.620.870.876.1Net revenue

132.2120.9482.4441.0Operating expenses:Cost of sales

30.626.1115.494.4Research and development

30.76.9146.267.7Selling and marketing

45.346.5175.5168.6Segment contribution

$
25.6$
41.4$
45.3$
.3Segment margin

19.4%34.2%9.4%25.0%Adjusted gross profit (1)

$
.6$
94.8$
367.0$
347.2Adjusted gross margin

76.9%78.4%76.1%78.7%(1)Adjusted gross profit represents net revenue less

adjusted cost of sales and excludes amortization of

acquired intangibles. Pro forma adjustments for the

respective periods include the following: Acquisition and licensing

$
-$
-$
-$
.6Actavis Specialty Brands net revenue increased 9 percent to $132.2 million in the fourth quarter. The increase was due to higher sales of key promoted products including Generess® Fe and Rapaflo® and the addition of Kadian®, which was acquired with the acquisition
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Watson to Acquire Actavis Group for EUR4.25 Billion
2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
4. Watson and Actavis Receive FTC Second Request
5. Watson Announces New Name -- Actavis -- for Global Operations
6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
9. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
10. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
11. Aethlon Medical Note: Fiscal Year Revenue Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 2015  Dr. Yair Walzer has added a ... issues often caused by menopause. The MonaLisa Touch™, an in-office ... FDA clearance in 2014. Dr. Walzer is one of the ... the special fractional CO 2 laser specifically designed to ... In 2010 there were greater than 46M women ...
(Date:5/29/2015)... South Carolina , May 29, 2015 ... have announced a collaboration designed to provide therapeutic clinical ... majority of cancer patients living in U.S. communities. ... Health to harness the power of big data and ... thousands of patients to enable ,accrual on demand, for ...
(Date:5/29/2015)... , May 29, 2015 /CNW/ - Covalon Technologies ... advanced medical technologies company, is delighted to announce ... March 31, 2015, which includes revenue for three ... quarter of $264,340. Revenue from advanced wound care product ... 31, 2015 increased 24% to $1,742,672 compared to ...
Breaking Medicine Technology:The Newest FDA-Cleared Breakthrough In Women's Health Treatments 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 3New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 4Covalon Announces Strong Second Quarter Results 2Covalon Announces Strong Second Quarter Results 3
... 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: ... specializes in the development and sale of patented ... generics and active pharmaceutical ingredients (API) announced that ... Macrolide Facility (JCM) has passed the internal quality ...
... NEW YORK, Nov. 9, 2011 ... research report is available in its ... and Reimbursement in Europe - Reference ... to Innovative Drugs Pose Significant Challenge ...
Cached Medicine Technology:JCM Passes Internal Quality Assessment for Azithromycin API Production 2JCM Passes Internal Quality Assessment for Azithromycin API Production 3Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 2Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 3Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 4Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 5Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 6Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 7
(Date:5/29/2015)... York, NY (PRWEB) May 29, 2015 ... USA Today, with a circulation of approximately 250,000 and ... distributed nationally, through a vast social media strategy, and ... outlets. To explore the digital version of the campaign, ... cover of the print publication. Inside, the actress, model ...
(Date:5/29/2015)... Vancouver, BC (PRWEB) May 29, 2015 ... PhysioCare & Sports Rehab, has recently stated in a ... “hide and suffer”. Urinary Continence is commonly seen as ... hesitate before seeking help. Expert physiotherapists like Shaila Jiwa ... about the condition. , Incontinence is a condition ...
(Date:5/29/2015)... 2015 Dr. Rodger Murphree, author ... Syndrome is now offering free weekly call in ... natural ways to reduce symptoms associated with fibromyalgia ... and brain fog. , To find out ... Fibromyalgia call in teleconferences simply go to ...
(Date:5/29/2015)... 2015 Javlin continues to fulfill its ... and a larger team, with the intention to better ... share in the U.S. and Canada. , Javlin Inc., ... significant growth in 2014 with its strongest earnings to ... integration platform, CloverETL. To accelerate further progress and ensure ...
(Date:5/29/2015)... 29, 2015 The FSH ... the science of the little-known and incurable disease, ... co-funding the second FSHD Trial Preparedness Workshop. The ... the University of Rochester Medical Center in Rochester, ... from around the world, including representatives from industry, ...
Breaking Medicine News(10 mins):Health News:Patients of Urinary Incontinence Should Not "Hide And Suffer," States Physiotherapist from Burnaby Physiotherapy Clinic 2Health News:Growth of Data Integration Platform CloverETL Continues in North America 2Health News:International Conference Brings Together Key Stakeholders to Advance Clinical Trial Readiness for FSHD 2Health News:International Conference Brings Together Key Stakeholders to Advance Clinical Trial Readiness for FSHD 3
... ... IT GRC Solutions Provider , ... Farmington Hills, Mich. (PRWEB) March 31, 2010 -- TruArx, the leading provider ... of Eric Rosenberg as chief financial officer. Rosenberg brings more than 20 ...
... ... of stir bars from use in granular slurries. Manufactured under protected processes, they have up ... , ... 30, 2010 -- Magnetic stirring bars, used to stir and mix everything from solutions in ...
... ... "America’s Veterinarian" Dr. Marty Becker chose his"Dr. Becker,s Best" products from ... trade show. The veterinarian for "Good Morning America" and "The Dr. ... contributor to PARADE magazine, Dr. Becker sent his team of pet ...
... ... ... International (TNI) announced the creation of GoNoni.com, a one-stop-shop for all Tahitian Noni communication ... of Independent Product Consultants (IPCs) at its International Leadership Conference in Anaheim, CA. Since that ...
... , ... items and Once in a Lifetime Experiences helped The Leukemia & Lymphoma Society exceed their ... ... to be the exclusive supplier of celebrity and music autographed collectibles for the ...
... , ... exams this season! From April 1 – May 30, people age 65 and older can call ... the US. , ... -- Spring… a time of change, but don’t worry if you don’t have the change to ...
Cached Medicine News:Health News:Spinfinity™ Magnetic Stirring Bars From Bel-Art Products Deliver Up to Three Times Wear Resistance 2Health News:Dr. Marty Becker Picks Best In Show at Global Pet Expo 2Health News:Dr. Marty Becker Picks Best In Show at Global Pet Expo 3Health News:Dr. Marty Becker Picks Best In Show at Global Pet Expo 4Health News:GoNoni.com Launched by Tahitian Noni International 2Health News:Autograph Store Sponsors The Leukemia Ball Charity Auction 2Health News:Autograph Store Sponsors The Leukemia Ball Charity Auction 3Health News:EyeCare America Ushers in the New Season and Springs for Eye Exams for Qualified Seniors 2Health News:EyeCare America Ushers in the New Season and Springs for Eye Exams for Qualified Seniors 3
9mm Gently Curved Jaws, WIth Lock, in Titanium....
5mm Gently Curved Wing Span, With Centering Pin, Low Profile; in stainless steel....
Retractable, straight double Lancet Blade, 15 Degree Angle , available in variations; Titanium handle...
10mm Tip to Bend, 0.3mm Y Tip; In Titanium....
Medicine Products: